Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma

Overview of attention for article published in Cancer Immunology, Immunotherapy, July 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

twitter: 8 X users
patent: 19 patents

facebook: 3 Facebook pages

Citations

dimensions_citation: 321 Dimensions

Readers on

mendeley: 283 Mendeley

Summary X Patents Facebook Dimensions citations

So far, Dimensions has found 321 publications that cite this research output.

321

The most recent citing publications are shown below. View all 321 publications that cite this research output on Dimensions.

Treatment advances in high-grade gliomas

Article in Frontiers in Oncology (April 2024)

Targeting Interleukin-13 Receptor α2 and EphA2 in Aggressive Breast Cancer Subtypes with Special References to Chimeric Antigen Receptor T-Cell Therapy

Article in International Journal of Molecular Sciences (March 2024)

Current approaches in glioblastoma multiforme immunotherapy

Article in Clinical and Translational Oncology (March 2024)